162 related articles for article (PubMed ID: 35128368)
1.
Lord SJ; Bahlmann K; O'Connell DL; Kiely BE; Daniels B; Pearson SA; Beith J; Bulsara MK; Houssami N
EClinicalMedicine; 2022 Feb; 44():101282. PubMed ID: 35128368
[TBL] [Abstract][Full Text] [Related]
2. Characteristics and survival of de novo and recurrent metastatic breast cancer in New Zealand.
Lao C; Kuper-Hommel M; Elwood M; Campbell I; Edwards M; Lawrenson R
Breast Cancer; 2021 Mar; 28(2):387-397. PubMed ID: 33044617
[TBL] [Abstract][Full Text] [Related]
3. Differential presentation and survival of de novo and recurrent metastatic breast cancer over time: 1990-2010.
Malmgren JA; Mayer M; Atwood MK; Kaplan HG
Breast Cancer Res Treat; 2018 Jan; 167(2):579-590. PubMed ID: 29039120
[TBL] [Abstract][Full Text] [Related]
4. Genomic Characterization of
Garrido-Castro AC; Spurr LF; Hughes ME; Li YY; Cherniack AD; Kumari P; Lloyd MR; Bychkovsky B; Barroso-Sousa R; Di Lascio S; Jain E; Files J; Mohammed-Abreu A; Krevalin M; MacKichan C; Barry WT; Guo H; Xia D; Cerami E; Rollins BJ; MacConaill LE; Lindeman NI; Krop IE; Johnson BE; Wagle N; Winer EP; Dillon DA; Lin NU
Clin Cancer Res; 2021 Feb; 27(4):1105-1118. PubMed ID: 33293374
[TBL] [Abstract][Full Text] [Related]
5. HR
Torrisi R; Jacobs F; Miggiano C; De Sanctis R; Santoro A
Drugs Context; 2023; 12():. PubMed ID: 36926051
[TBL] [Abstract][Full Text] [Related]
6. The clinicomolecular landscape of de novo versus relapsed stage IV metastatic breast cancer.
Seltzer S; Corrigan M; O'Reilly S
Exp Mol Pathol; 2020 Jun; 114():104404. PubMed ID: 32067942
[TBL] [Abstract][Full Text] [Related]
7. De Novo Versus Recurrent HER2-Positive Metastatic Breast Cancer: Patient Characteristics, Treatment, and Survival from the SystHERs Registry.
Tripathy D; Brufsky A; Cobleigh M; Jahanzeb M; Kaufman PA; Mason G; O'Shaughnessy J; Rugo HS; Swain SM; Yardley DA; Chu L; Li H; Antao V; Hurvitz SA
Oncologist; 2020 Feb; 25(2):e214-e222. PubMed ID: 32043771
[TBL] [Abstract][Full Text] [Related]
8. Use and results of systemic treatments for de novo and recurrent metastatic breast cancer: a population-based cohort study.
Lao C; Kuper-Hommel M; Campbell I; Elwood M; Lawrenson R
N Z Med J; 2021 Nov; 134(1545):47-59. PubMed ID: 34788271
[TBL] [Abstract][Full Text] [Related]
9. Changes in Overall Survival over Time for Patients with de novo Metastatic Breast Cancer.
Iwase T; Shrimanker TV; Rodriguez-Bautista R; Sahin O; James A; Wu J; Shen Y; Ueno NT
Cancers (Basel); 2021 May; 13(11):. PubMed ID: 34071219
[TBL] [Abstract][Full Text] [Related]
10. Epidemiology of De Novo Metastatic Breast Cancer.
Daily K; Douglas E; Romitti PA; Thomas A
Clin Breast Cancer; 2021 Aug; 21(4):302-308. PubMed ID: 33750642
[TBL] [Abstract][Full Text] [Related]
11. Characteristics and post-metastasis survival of recurrent metastatic breast cancer over time - An Australian population-based record linkage study, 2001-2016.
Lord SJ; Kiely BE; O'Connell DL; Daniels B; Beith J; Smith AL; Pearson SA; Chiew KL; Bulsara MK; Houssami N
Eur J Cancer; 2024 Jan; 197():113468. PubMed ID: 38061215
[TBL] [Abstract][Full Text] [Related]
12. Occurrence and characteristics of patients with de novo advanced breast cancer according to patient and tumor characteristics - A retrospective analysis of a real world registry.
Müller V; Hein A; Hartkopf AD; Fasching PA; Kolberg HC; Hadji P; Tesch H; Häberle L; Ettl J; Lüftner D; Wallwiener M; Beckmann MW; Schneeweiss A; Belleville E; Uhrig S; Wimberger P; Hielscher C; Meyer J; Wurmthaler LA; Kurbacher CM; Wuerstlein R; Untch M; Janni W; Taran FA; Lux MP; Wallwiener D; Brucker SY; Fehm TN; Michel LL
Eur J Cancer; 2022 Sep; 172():13-21. PubMed ID: 35728342
[TBL] [Abstract][Full Text] [Related]
13. Demographic and Clinical Features of Patients with Metastatic Breast Cancer: A Retrospective Multicenter Registry Study of the Turkish Oncology Group.
Dogan I; Aksoy S; Cakar B; Basaran G; Ercelep O; Molinas Mandel N; Korkmaz T; Gokmen E; Sener C; Aydiner A; Saip P; Eralp Y
Cancers (Basel); 2023 Mar; 15(6):. PubMed ID: 36980554
[TBL] [Abstract][Full Text] [Related]
14. De novo metastatic breast cancer in patients with a small locoregional tumour (T1-T2/N0): Characteristics and prognosis.
Gaillard T; Carton M; Mailliez A; Desmoulins I; Mouret-Reynier MA; Petit T; Leheurteur M; Dieras V; Ferrero JM; Uwer L; Guiu S; Gonçalves A; Levy C; Debled M; Dalenc F; Patsouris A; Bachelot T; Eymard JC; Chevrot M; Conversano A; Robain M; Hequet D
Eur J Cancer; 2021 Oct; 158():181-188. PubMed ID: 34689042
[TBL] [Abstract][Full Text] [Related]
15. Survival with metastatic breast cancer based on initial presentation, de novo versus relapsed.
den Brok WD; Speers CH; Gondara L; Baxter E; Tyldesley SK; Lohrisch CA
Breast Cancer Res Treat; 2017 Feb; 161(3):549-556. PubMed ID: 28000014
[TBL] [Abstract][Full Text] [Related]
16. Real-world evidence of the management and prognosis of young women (⩽40 years) with
Mallet A; Lusque A; Levy C; Pistilli B; Brain E; Pasquier D; Debled M; Thery JC; Gonçalves A; Desmoulins I; De La Motte Rouge T; Faure C; Ferrero JM; Eymard JC; Mouret-Reynier MA; Patsouris A; Cottu P; Dalenc F; Petit T; Payen O; Uwer L; Guiu S; Frenel JS
Ther Adv Med Oncol; 2022; 14():17588359211070362. PubMed ID: 35082924
[TBL] [Abstract][Full Text] [Related]
17. Characteristics and follow-up of metastatic breast cancer in Ethiopia: A cohort study of 573 women.
Weiner CM; Mathewos A; Addissie A; Ayele W; Aynalem A; Wondemagegnehu T; Wienke A; Jemal A; Zerche P; Thomssen C; Seidler A; Kantelhardt EJ
Breast; 2018 Dec; 42():23-30. PubMed ID: 30149234
[TBL] [Abstract][Full Text] [Related]
18. Impact of prior (neo)adjuvant trastuzumab (NAT) exposure on the efficacy of HER2-targeted therapy for metastatic breast cancer.
Kanjanapan Y; Lok SW; Gibbs P; De Boer R; Yeo B; Greenberg S; Barnett F; Knott L; Richardson G; Wong R; Nottage M; Collins IM; Torres J; Lombard J; Johns J; Harold M; Malik L
Breast Cancer Res Treat; 2020 Nov; 184(1):87-95. PubMed ID: 32779037
[TBL] [Abstract][Full Text] [Related]
19. Survival and disease characteristics of de novo versus recurrent metastatic breast cancer in a cohort of young patients.
McKenzie HS; Maishman T; Simmonds P; Durcan L; ; Eccles D; Copson E
Br J Cancer; 2020 May; 122(11):1618-1629. PubMed ID: 32231292
[TBL] [Abstract][Full Text] [Related]
20. Change in Survival in Metastatic Breast Cancer with Treatment Advances: Meta-Analysis and Systematic Review.
Caswell-Jin JL; Plevritis SK; Tian L; Cadham CJ; Xu C; Stout NK; Sledge GW; Mandelblatt JS; Kurian AW
JNCI Cancer Spectr; 2018 Nov; 2(4):pky062. PubMed ID: 30627694
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
